Yıl: 2021 Cilt: 13 Sayı: 4 Sayfa Aralığı: 446 - 451 Metin Dili: İngilizce DOI: 10.4274/jcrpe.galenos.2020.2020.0107 İndeks Tarihi: 18-06-2022

Clinical Management in Systemic Type Pseudohypoaldosteronism Due to SCNN1B Variant and Literature Review

Öz:
Systemic pseudohypoaldosteronism (PHA) is a rare, salt-wasting syndrome that is caused by inactivating variants in genes encoding epithelial sodium channel subunits. Hyponatremia, hyperkalemia, metabolic acidosis, increased aldosterone and renin levels are expected findings in PHA. Clinical management is challenging due to high dose oral replacement therapy. Furthermore, patients with systemic PHA require life-long therapy. Here we report a patient with systemic PHA due to SCNN1B variant whose hyponatremia and hyperkalemia was detected at the 24th hour of life. Hyperkalemia did not improve with conventional treatments and dialysis was required. He also developed myocarditis and hypertension in follow-up. Challenges for diagnosis and treatment in this patient are discussed herein. In addition, published evidence concerning common features of patients with SCNN1B variant are reviewed.
Anahtar Kelime:

Belge Türü: Makale Makale Türü: Olgu Sunumu Erişim Türü: Erişime Açık
  • 1. Rossier BC. The epithelial sodium channel (ENaC) and the control of blood pressure. J Am Soc Nephrol 1997;8:980-992. Epub 2013 Dec 12
  • 2. Garty H, Palmer LG. Epithelial sodium channels: function, structure, and regulation. Physiol Rev 1997;77:359-396.
  • 3. Canessa CM, Schild L, Buell G, Thorens B, Gautschi I, Horisberger JD, Rossier BC. Amiloride-sensitive epithelial Na+ channel is made of three homologous subunits. Nature 1994;367:463-467.
  • 4. Amin N, Alvi NS, Barth JH, Field HP, Finlay E, Tyerman K, Frazer S, Savill G, Wright NP, Makaya T, Mushtag T. Pseudohypoaldosteronism type 1: clinical features and management in infancy. Endocrinol Diabetes Metab Case Rep 2013;2013:130010. Epub 2013 Aug 30
  • 5. Kala Ahluwalia, Dasouki M, Lennon A. Phenotypic variation of autosomal recessive pseudohypoaldosteronism type 1: a case in point. Clin Case Rep 2014;2:326-330. Epub 2014 Sep 15
  • 6. Cayir A, Demirelli Y, Yıldız D, Kahveci H, Yaralı O, Kurnaz E, Vuralli D, Demirbilek H. Systemic pseudohypoaldosteronism type 1 due to 3 novel mutations in SCNN1A and SCNN1B genes. Horm Res Paediatr 2019;91:175-185. Epub 2019 Apr 24
  • 7. Gopal-Kothandapani JS, Doshi AB, Smith K, Christian M, Mushtaq T, Banerjee I, Padidela R, Ramakrishnan R, Owen C, Cheetham T, Dimitri P. Phenotypic diversity and correlation with the genotypes of pseudohypoaldosteronism type 1. J Pediatr Endocrinol Metab 2019;32:959-967.
  • 8. Saxena A, Hanukoglu I, Saxena D, Thompson RJ, Gardiner RM, Hanukoglu A. Novel mutations responsible for autosomal recessive multisystem pseudohypoaldosteronism and sequence variants in epithelial sodium channel α-,β-,ϒ- subunit genes. J Clin Endocrinol Metab 2002;87:3344-3350.
  • 9. Nur N, Lang C, Hodax JK, Quintos JB. Systemic pseudohypoaldosteronism type I: A case report and review of the literature. Case Rep Pediatr 2017;2017:7939854. Epub 2017 Apr 18
  • 10. Belot A, Ranchin B, Fichtner C, Pujo L, Rossier BC, Liutkus A, Morlat C, Nicolino M, Zennaro MC, Cochat P. Pseudohypoaldosteronisms, report on a 10- patient series. Nephrol Dial Transplant 2008;23:1636-1641.
  • 11. Nobel YR, Lodish MB, Raygada M, Rivero JD, Faucz FR, Abraham SB, Lyssikatos C, Belyavskaya E, Stratakis CA, Zilbermint M. Pseudohypoaldosteronism type 1 due to novel variants of SCNN1B gene. Endocrinol Diabetes Metab Case Rep 2016;2016:150104. Epub 2016 Jan 7
  • 12. Thomas CP, Zhou J, Liu KZ, Mick VE, MacLaughlin E, Knowles M. Systemic pseudohypoaldosteronism from deletion of the promoter region of the human β epithelial Na+ channel subunit. Am J Respir Cell Mol Biol 2002;27:314-319.
  • 13. Edelheit O, Hanukoglu I, Gizewska M, Kandemir N, TenenbaumRakover Y, Yurdakök M, Zajaczek S, Hanukoglu A. Novel mutations in epithelial sodium channel (ENaC) subunit genes and phenotypic expression of multisystem pseudohypoaldosteronism. Clin Endocrinol (Oxf) 2005;62:547-553.
  • 14. Güran T, Degirmenci S, Bulut IK, Say A, Riepe FG, Güran Ö. Critical points in the management of pseudohypoaldosteronism type 1. J Clin Res Pediatr Endocrinol 2011;3:98-100. Epub 2011 Jun 8
  • 15. Saravanapandian N, Paul S, Matthai J. Pseudohypoaldosteronism type 1: a rare cause of severe dyselectrolytemia and cardiovascular collapse in neonates. J Clin Neonatol 2012;1:224-226.
  • 16. Sharma R, Pandey M, Kanwal SK, Zennaro MC. Pseudohypoalsteronism type 1: management issues. Indian Pediatr 2013;50:331-333.
  • 17. Önder A, Çetinkaya S, Kara C, Zenciroğlu A, Aycan Z. Multisystemic severe form pseudohypoaldosteronism: can gastrostomy be useful in management? Turkish J Pediatr Dis 2016;2:134-136.
  • 18. Chang SS, Grunder S, Hanukoglu A, Rösler A, Mathew PM, Hanukoglu I, Schild L, Lu Y, Shimkets RA, Nelson-Williams C, Rossier BC, Lifton RP. Mutations in subunits of the epithelial sodium channel cause salt wasting with hyperkalemic acidosis, pseudohypoaldosteronism type 1. Nat Genet 1996;12:248-253.
  • 19. Dogan CS, Durmaz, Parlak M, Akan M, Akcurin S, İffet B, Afig B. A novel splice site mutation of the beta subunit gene of epithelial sodium channel (ENaC) in one Turkish patient with systemic form of pseudohypoaldosteronism type 1. J Pediatr Endocrinol Metab 2012;25:1035-1039.
  • 20. Hanukoglu A, Edelheit O, Shriki Y, Gizewska M, Dascal N, Hanukoglu I. Renin-aldosteron response, urinary Na/K ratio and growth in pseudohypoaldosteronism patients with mutations in epithelial sodium channel (ENaC) subunit genes. J Steroid Biochem Mol Biol. 2008;111:268-274. Epub 2008 Jun 26
  • 21. Kerem E, Bistritzer T, Hanukoglu A, Hofmann T, Zhou Z, Bennett W, MacLaughlin E, Barker P, Nash M, Quittell L, Boucher R, Knowles MR. Pulmonary epithelial sodium-channel dysfunction and excess airway liquid in pseudohypoaldosteronism. N Engl J Med 1999;341:156-162.
APA Karacan Küçükali G (2021). Clinical Management in Systemic Type Pseudohypoaldosteronism Due to SCNN1B Variant and Literature Review. , 446 - 451. 10.4274/jcrpe.galenos.2020.2020.0107
Chicago Karacan Küçükali Gülin Clinical Management in Systemic Type Pseudohypoaldosteronism Due to SCNN1B Variant and Literature Review. (2021): 446 - 451. 10.4274/jcrpe.galenos.2020.2020.0107
MLA Karacan Küçükali Gülin Clinical Management in Systemic Type Pseudohypoaldosteronism Due to SCNN1B Variant and Literature Review. , 2021, ss.446 - 451. 10.4274/jcrpe.galenos.2020.2020.0107
AMA Karacan Küçükali G Clinical Management in Systemic Type Pseudohypoaldosteronism Due to SCNN1B Variant and Literature Review. . 2021; 446 - 451. 10.4274/jcrpe.galenos.2020.2020.0107
Vancouver Karacan Küçükali G Clinical Management in Systemic Type Pseudohypoaldosteronism Due to SCNN1B Variant and Literature Review. . 2021; 446 - 451. 10.4274/jcrpe.galenos.2020.2020.0107
IEEE Karacan Küçükali G "Clinical Management in Systemic Type Pseudohypoaldosteronism Due to SCNN1B Variant and Literature Review." , ss.446 - 451, 2021. 10.4274/jcrpe.galenos.2020.2020.0107
ISNAD Karacan Küçükali, Gülin. "Clinical Management in Systemic Type Pseudohypoaldosteronism Due to SCNN1B Variant and Literature Review". (2021), 446-451. https://doi.org/10.4274/jcrpe.galenos.2020.2020.0107
APA Karacan Küçükali G (2021). Clinical Management in Systemic Type Pseudohypoaldosteronism Due to SCNN1B Variant and Literature Review. Journal of Clinical Research in Pediatric Endocrinology, 13(4), 446 - 451. 10.4274/jcrpe.galenos.2020.2020.0107
Chicago Karacan Küçükali Gülin Clinical Management in Systemic Type Pseudohypoaldosteronism Due to SCNN1B Variant and Literature Review. Journal of Clinical Research in Pediatric Endocrinology 13, no.4 (2021): 446 - 451. 10.4274/jcrpe.galenos.2020.2020.0107
MLA Karacan Küçükali Gülin Clinical Management in Systemic Type Pseudohypoaldosteronism Due to SCNN1B Variant and Literature Review. Journal of Clinical Research in Pediatric Endocrinology, vol.13, no.4, 2021, ss.446 - 451. 10.4274/jcrpe.galenos.2020.2020.0107
AMA Karacan Küçükali G Clinical Management in Systemic Type Pseudohypoaldosteronism Due to SCNN1B Variant and Literature Review. Journal of Clinical Research in Pediatric Endocrinology. 2021; 13(4): 446 - 451. 10.4274/jcrpe.galenos.2020.2020.0107
Vancouver Karacan Küçükali G Clinical Management in Systemic Type Pseudohypoaldosteronism Due to SCNN1B Variant and Literature Review. Journal of Clinical Research in Pediatric Endocrinology. 2021; 13(4): 446 - 451. 10.4274/jcrpe.galenos.2020.2020.0107
IEEE Karacan Küçükali G "Clinical Management in Systemic Type Pseudohypoaldosteronism Due to SCNN1B Variant and Literature Review." Journal of Clinical Research in Pediatric Endocrinology, 13, ss.446 - 451, 2021. 10.4274/jcrpe.galenos.2020.2020.0107
ISNAD Karacan Küçükali, Gülin. "Clinical Management in Systemic Type Pseudohypoaldosteronism Due to SCNN1B Variant and Literature Review". Journal of Clinical Research in Pediatric Endocrinology 13/4 (2021), 446-451. https://doi.org/10.4274/jcrpe.galenos.2020.2020.0107